quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:18:47·14d
SECFiling
Becton Dickinson and Company logo

Becton Dickinson and Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

BDX· Becton Dickinson and Company
Health Care
Original source

Companies

  • BDX
    Becton Dickinson and Company
    Health Care

Recent analyst ratings

  • Apr 10UpdateGoldman$167.00
  • Feb 10UpdateBarclays$202.00
  • Feb 3UpdateCitigroup$233.00
  • Sep 25UpdateRBC Capital Mkts$211.00
  • May 22UpdateCitigroup$185.00
  • May 2UpdatePiper Sandler$185.00

Related

  • PR8d
    BD Earns Industry Top Honors for Transparency, Resiliency and Partnership
  • ANALYST13d
    Goldman resumed coverage on Becton Dickinson with a new price target
  • PR14d
    BD to Announce Financial Results for its Second Quarter of Fiscal 2026
  • PR14d
    Rick Byrd to Retire from BD
  • PR15d
    For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System
  • PR16d
    BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
  • PR17d
    When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight
  • INSIDER17d
    SEC Form 4 filed by Neal Shana Carol
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022